[High-throughput sequencing of frozen and paraffin-embedded tumor and normal tissue].
Until now high-throughput sequencing of tumor samples relied on DNA isolated from fresh frozen tissues, the preparation of which, however, is relatively laborious. The use of preserved material, i.e. from tissue banks, could help to avoid this limitation and would enable the reanalysis of diverse clinical trials. So far we have shown that formalin-fixed paraffin-embedded (FFPE) tissue samples can be used for genomic re-sequencing processes. FFPE samples are amply available from surgical tumor resections and histopathological diagnosis, and comprise tissue from precursor lesions, primary tumors, and lymphogenic and/or hematogenic metastases. To generate models which predict the response to therapy, FFPE tissue also has the advantage that it is available from a variety of clinical trials. Second generation sequencing techniques are not only applicable to snap frozen and FFPE tissues for whole genome analyses but also for targeted resequencing approaches. In addition, the detection of copy number variations and mutations in FFPE tissues can be obtained within one sequencing run. The possibility of using genome-wide technologies irrespective of the mode of storage facilitates the retrieval of useful material and is a prerequisite for subsequent computational modelling approaches.
Kerick
M
M
Cancer Genomics Group, Department of Vertebrate Genomics, Max-Planck-Institut für molekulare Genetik, Berlin.
Timmermann
B
B
Schweiger
M-R
MR
D056915:DNA Copy Number Variations / Q000235:genetics; D004252:DNA Mutational Analysis; D005404:Fixatives; D005557:Formaldehyde; D005629:Frozen Sections; D059014:High-Throughput Nucleotide Sequencing / Q000379:methods*; D006801:Humans; D009369:Neoplasms / Q000235:genetics* / Q000473:pathology*; D016612:Paraffin Embedding; D011237:Predictive Value of Tests; D011379:Prognosis
D005404:Fixatives; D005557:Formaldehyde
J Pathol. 2010 Jan;220(2):231-43
19918804
Genome Biol. 2009;10(3):R25
19261174
Genes Chromosomes Cancer. 1997 Dec;20(4):399-407
9408757
Drug Resist Updat. 2008 Jun;11(3):99-109
18515176
Nat Biotechnol. 2008 Oct;26(10):1135-45
18846087
Nature. 2005 Sep 15;437(7057):376-80
16056220
Genome Res. 2008 Nov;18(11):1851-8
18714091
Nat Rev Genet. 2010 Jan;11(1):31-46
19997069
J Clin Oncol. 2005 Sep 1;23(25):5900-9
16043828
Nat Chem Biol. 2006 Dec;2(12):689-700
17108987
Nat Genet. 2007 Mar;39(3):347-51
17293865
Nature. 2008 Apr 3;452(7187):553-63
18385729
Hum Mol Genet. 2009 Oct 15;18(R2):R163-8
19808792
PLoS One. 2007 Jun 20;2(6):e537
17579711
Nature. 2000 May 18;405(6784):311-9
10830953